EGFL7 and hepatocellular carcinoma: Our study showed that Egfl7 expression in HCC promotes tumour progression in a paracrine manner by recruiting and activating LFs into CAFs, which results from elevated FAK and AKT phosphorylation by signal transduction of ανβ3 integrin.